These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37453164)

  • 41. Detecting and prioritizing biosynthetic gene clusters for bioactive compounds in bacteria and fungi.
    Tran PN; Yen MR; Chiang CY; Lin HC; Chen PY
    Appl Microbiol Biotechnol; 2019 Apr; 103(8):3277-3287. PubMed ID: 30859257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategies to access biosynthetic novelty in bacterial genomes for drug discovery.
    Hemmerling F; Piel J
    Nat Rev Drug Discov; 2022 May; 21(5):359-378. PubMed ID: 35296832
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence.
    Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG
    Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plant natural products: back to the future or into extinction?
    McChesney JD; Venkataraman SK; Henri JT
    Phytochemistry; 2007 Jul; 68(14):2015-22. PubMed ID: 17574638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor.
    McClung DJ; Du Y; Antonich DJ; Bonet B; Zhang W; Traxler MF
    mBio; 2022 Jun; 13(3):e0039322. PubMed ID: 35608300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioinformatics approaches and software for detection of secondary metabolic gene clusters.
    Fedorova ND; Moktali V; Medema MH
    Methods Mol Biol; 2012; 944():23-45. PubMed ID: 23065606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type II Polyketide Synthases: A Bioinformatics-Driven Approach.
    Xie S; Zhang L
    Chembiochem; 2023 May; 24(9):e202200775. PubMed ID: 36856079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted Discovery of Cryptic Metabolites with Antiproliferative Activity.
    Han EJ; Lee SR; Hoshino S; Seyedsayamdost MR
    ACS Chem Biol; 2022 Nov; 17(11):3121-3130. PubMed ID: 36228140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metagenomic sequencing-driven multidisciplinary approaches to shed light on the untapped microbial natural products.
    Wu C; Yin Y; Zhu L; Zhang Y; Li YZ
    Drug Discov Today; 2022 Mar; 27(3):730-742. PubMed ID: 34775105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Informatics and Computational Methods in Natural Product Drug Discovery: A Review and Perspectives.
    Romano JD; Tatonetti NP
    Front Genet; 2019; 10():368. PubMed ID: 31114606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring cyanobacterial genomes for natural product biosynthesis pathways.
    Micallef ML; D'Agostino PM; Al-Sinawi B; Neilan BA; Moffitt MC
    Mar Genomics; 2015 Jun; 21():1-12. PubMed ID: 25482899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cheminformatic Analysis of Natural Product Fragments.
    Reker D
    Prog Chem Org Nat Prod; 2019; 110():143-175. PubMed ID: 31621013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracting data from the muck: deriving biological insight from complex microbial communities and non-model organisms with next generation sequencing.
    Solomon KV; Haitjema CH; Thompson DA; O'Malley MA
    Curr Opin Biotechnol; 2014 Aug; 28():103-10. PubMed ID: 24503479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diversifying microbial natural products for drug discovery.
    Knight V; Sanglier JJ; DiTullio D; Braccili S; Bonner P; Waters J; Hughes D; Zhang L
    Appl Microbiol Biotechnol; 2003 Oct; 62(5-6):446-58. PubMed ID: 12838377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bioinformatics tools for genome mining of polyketide and non-ribosomal peptides.
    Boddy CN
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):443-50. PubMed ID: 24174214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome Mining as New Challenge in Natural Products Discovery.
    Albarano L; Esposito R; Ruocco N; Costantini M
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32283638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The need to innovate sample collection and library generation in microbial drug discovery: a focus on academia.
    Hernandez A; Nguyen LT; Dhakal R; Murphy BT
    Nat Prod Rep; 2021 Mar; 38(2):292-300. PubMed ID: 32706349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benchmarking of two bioinformatic workflows for the analysis of whole-genome sequenced Staphylococcus aureus collected from patients with suspected sepsis.
    Shemirani MI; Tilevik D; Tilevik A; Jurcevic S; Arnellos D; Enroth H; Pernestig AK
    BMC Infect Dis; 2023 Jan; 23(1):39. PubMed ID: 36670352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accessing hidden microbial biosynthetic potential from underexplored sources for novel drug discovery.
    Li L
    Biotechnol Adv; 2023 Sep; 66():108176. PubMed ID: 37211187
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.